Uncovering a tumor suppressor for triple-negative breast cancers

John Albeck, Joan S. Brugge

Research output: Contribution to journalReview article

16 Scopus citations

Abstract

"Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.

Original languageEnglish (US)
Pages (from-to)638-640
Number of pages3
JournalCell
Volume144
Issue number5
DOIs
StatePublished - Mar 4 2011
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this